YOLFTbeta
Lavipharm S.A

Lavipharm S.A

LAVI · AT · Healthcare / Drug Manufacturers - Specialty & Generic

1.48EUR-0.00 (-0.14%)

Price History

Full chart

Market Stats

Previous Close1.48
Open1.46
Day Range1.45 – 1.51
52-Week Range0.7455 – 1.71
Volume24.57K
Market Cap267.78M
P/E (TTM)52.27
Forward P/E0.00
EPS0.03
Dividend Yield1.28%
Beta1.00
50-Day Avg1.59
200-Day Avg1.41

About

Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sale, and wholesaling of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, respiratory system, gastrointestinal system, and urology; and over the counter (OTC) drugs, such as antiseptics, anagelsics, and anti-lice treatment products. It also provides a range of skincare products focused on health. The company was founded in 1911 and is based in Paiania, Greece.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Telemaque Jean Lavidas
  • Employees269
  • Headquarters12, Agias Marinas Street, Paiania, Greece, 19002, Greece
  • Websitehttps://lavipharm.com

Leadership

  • Mr. Telemaque Jean LavidasCEO & Executive Board Member
  • Mr. Vassilis BaloumisGroup CFO & Investor Relations Officer
  • Mr. Panagiotis KousoulisChief Manufacturing & Operations Officer
  • Mr. Evangelos PaterakisChief Accountant
  • Ms. Mariza AntonakiChief People & Technology Officer
  • Mr. Nikos LadasChief Scientific Officer
  • Ms. Eleana NikolopoulouDirector of Legal & Compliance and Corporate Secretary
  • Mr. Ilias KonstantopoulosDirector of Marketing & Sales CHC
  • Dr. Katerina TsardakaDirector of Business Development & Acquisitions
  • Mr. Panagiotis GiannouleasDeputy CEO & Director

Financials

Income Statement

Currency: EUR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue30.30M26.37M31.14M31.81M34.06M33.59M37.64M39.72M46.01M47.84M52.95M62.58M
Growth (%)--12.96%+18.09%+2.14%+7.08%-1.38%+12.06%+5.54%+15.82%+3.98%+10.68%+18.20%
Cost of Revenue13.82M11.66M14.41M15.52M16.24M17.64M21.41M23.84M28.03M25.69M27.87M32.28M
Gross Profit16.47M14.70M16.73M16.29M17.82M15.94M16.22M15.89M17.97M22.15M25.08M30.30M
Gross Margin54.38%55.76%53.72%51.22%52.32%47.47%43.10%40.00%39.07%46.30%47.37%48.42%
Operating Expense30.80M16.51M12.57M1.69M12.80M11.92M10.95M10.51M14.13M17.56M19.61M21.30M
Operating Income-14.32M-1.80M4.16M14.60M5.02M4.02M5.27M5.38M3.84M4.59M5.47M9.01M
Operating Margin-47.28%-6.84%13.36%45.90%14.73%11.97%14.01%13.55%8.36%9.60%10.34%14.39%
EBITDA------6.80M6.23M5.58M9.60M10.20M14.56M
EBITDA Margin------18.06%15.69%12.13%20.07%19.26%23.26%
Net Income-26.09M-7.07M3.66M12.93M1.25M5.33M2.17M1.72M834.00K1.87M8.98M5.99M
Net Income Margin-86.10%-26.83%11.75%40.64%3.67%15.86%5.75%4.34%1.81%3.91%16.96%9.56%
R&D4.25M3.34M2.53M1.67M856.00K-753.00K812.00K854.00K430.00K631.00K344.00K
R&D as % of Total Revenue14.02%12.67%8.13%5.25%2.51%-2.00%2.04%1.86%0.90%1.19%0.55%
Interest Expense0000001.92M1.83M1.73M2.17M2.01M1.84M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%5.10%4.62%3.77%4.53%3.80%2.94%

Balance Sheet

Currency: EUR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets83.82M82.38M48.18M44.81M41.90M49.42M50.64M52.74M114.17M114.79M125.48M130.22M
Total Liabilities132.79M146.80M80.00M64.73M61.43M63.82M62.94M62.68M73.89M72.02M72.52M73.81M
Total Equity-26.00M-35.85M-31.82M-19.92M-19.53M-14.40M-12.30M-9.98M40.28M42.74M52.98M56.42M
Cash2.44M2.06M1.68M2.35M1.84M1.73M1.93M1.64M18.24M8.44M5.59M6.11M
Total Debt--56.76M39.77M38.49M37.21M36.26M-----
Net Debt------25.57M23.65M7.32M12.26M17.15M14.53M

Cash Flow

Currency: EUR2002-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.38M576.00K606.00K1.51M1.42M2.89M2.85M3.82M3.35M284.00K4.64M6.67M
Investing Cash Flow--1.15M-149.00K434.00K273.00K-1.02M-2.41M-1.47M-1.88M-35.59M---
Financing Cash Flow--2.46M-56.00K97.00K-1.11M-904.00K-595.00K-1.18M-2.23M48.85M---
Capital Expenditure01.20M23.00K97.00K350.00K1.03M2.42M1.48M1.92M35.62M4.05M9.64M4.62M
Free Cash Flow-------1.37M2.19M-32.27M-3.77M-5.00M2.05M
Dividends Paid------------3.38M
FCF to OCF-------48.21%57.40%-964.15%-1325.70%-107.84%30.71%
Dividend Paid to FCF------------165.17%

Earnings

Report DateFeb 28, 2007May 26, 2007Jul 31, 2007Nov 27, 2007Mar 24, 2008Jun 4, 2008Sep 1, 2008Sep 30, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015
EPS Estimate------------------------------------
EPS Actual0.080.06-0.25-0.25-0.17-0.08-0.22-0.150.36-0.03-0.14-0.20-0.10-0.16-0.170.24-0.13-0.07-0.07-0.30-0.14-0.11-0.10-0.06-0.11-0.12-0.12-0.37-0.03-1.05-0.09-0.26-0.05-0.11-0.09-0.13
Surprise------------------------------------
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-----------------------------

Key Statistics & Ratios

Market Cap267.78M
Enterprise Value293.66M
Trailing P/E52.27
Forward P/E0.00
Price / Sales3.81
Price / Book4.73
EPS0.03
Book Value0.33
Revenue (TTM)70.31M
Gross Profit (TTM)33.15M
EBITDA13.39M
Profit Margin8.17%
Operating Margin13.63%
Return on Equity10.22%
Return on Assets4.23%
Shares Outstanding170.78M
Shares Float64.01M
Beta1.00
Dividend Yield1.28%
Dividend Rate0.02
Payout Ratio68.49%

Dividends

20261×
0.02Jul 20, 2026
20251×
0.02Jul 17, 2025
20071×
0.16Aug 20, 2007
20051×
0.10Jun 30, 2005
20031×
0.10Jun 20, 2003
20021×
0.16Jun 27, 2002
20011×
0.15Jun 21, 2001
20001×
0.14Jul 3, 2000
19991×
0.10Jun 29, 1999
19981×
0.16Jul 1, 1998
19971×
0.15Jun 18, 1997
19961×
0.09Jun 20, 1996

Stock Splits

  • Nov 28, 2022159:148
  • Aug 1, 20221:3
  • Sep 3, 20071009:941
  • Nov 22, 1999369:278
  • Jul 23, 19992:1
  • Dec 17, 19981000:909
  • Jul 11, 1997364:341
  • Mar 17, 19976:5